Zeneca declares commitment to inherited disease diagnostics with launch of new test for liver and lung function
This article was originally published in Clinica
Zeneca Diagnostics has launched the first genetic test that will detect alpha-1-antitrypsin deficiency (AAT), which is associated with adult emphysema and progressive liver cirrhosis in children.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.